2022 ACC/AHA 冠狀動脈血運重建指南(第 1 部分)

Published on

討論新的有爭議的 ACC/AHA 指南更新,這降低了 CABG 作為三支血管疾病和正常 LV 功能的 CAD 患者治療的證據水平。 該小組反駁了 CABG 與藥物治療相比的益處和 CABG 類別指定的減少,以及使用 ISCHEMIA 和其他類似試驗得出此類比較證據結論。

The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

Video Player is loading.
Current Time 0:00
Duration -:-
Loaded: 0%
Stream Type LIVE
Remaining Time -:-
 
1x
  • Chapters
  • descriptions off, selected
  • subtitles off, selected

    Media Error

    An error occurred while trying to load the media. Please, try again later.

    Retrying, please wait

    Try Again


    Other News

    Cards

    • 二尖瓣修復的最新進展和趨勢(第 4 部分)

      Published on

      在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    • 二尖瓣修復的最新進展和趨勢(第 3 部分)

      Published on

      在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    • 二尖瓣修復的最新進展和趨勢(第 2 部分)

      Published on

      在本系列中,美敦力首席醫療官兼心臟外科副總裁 Pieter Kappetein 教授、紐約大學的 Eugene Grossi 博士、普萊諾 Baylor Scott & White 的 Robert L. Smith 博士和華盛頓的 Puja Kachroo 博士 聖路易斯大學醫學院討論二尖瓣患者的治療已經發生和即將發生的變化。 詳細了解 MICS 程序的重要性、設置機器人程序的關鍵步驟以及二尖瓣心臟團隊的重要性。

      The information in this content is intended only for healthcare professionals in countries where these Medtronic products and therapies are approved or available for use. The content may not be approved for use in your specific region or country. Please review applicable product labeling for your country for indications and instructions prior to viewing.

      Access Now

    "-- SEO4AJAX --" "seo4ajax Access"

    "-- SEO4AJAX --" "Init" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"zh","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-1"}

    "-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"zh","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-1"} 200 "https://campus.meplis.com/mycvsurgery/ww/zh/news/2022-accaha-coronary-revascularization-guidelines-segment-1"

    "-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mycvsurgery","regionsSlug":"ww","languagesSlug":"zh","newsSlug":"2022-accaha-coronary-revascularization-guidelines-segment-1"} 200 "https://campus.meplis.com/mycvsurgery/ww/zh/news/2022-accaha-coronary-revascularization-guidelines-segment-1"

    "-- SEO4AJAX --" "Timeout: " 5 " seconds"

    "-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mycvsurgery/ww/zh/news/2022-accaha-coronary-revascularization-guidelines-segment-1"

    "-- SEO4AJAX --" "Bugsnag Called"